Concepedia
Statistics
Publications
24
Citations
1.7K
H-Index
19
Active since
1997
Affiliations
Nova Southeastern University(Current)
McGill University
Medical University of South Carolina
Vaccine & Gene Therapy Institute of Florida
Jewish General Hospital
Vladimir Beljanski is an author at Nova Southeastern University specializing in life sciences, molecular biology, and oncology.
Publications per year
1997–2022
Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
Kevin J. French, Yan Zhuang, Lynn W. Maines et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 315 citations · Full text
Medicine, Oncology, Pharmacology +17
Cellular Oxidative Stress Response Controls the Antiviral and Apoptotic Programs in Dengue Virus-Infected Dendritic Cells
David Olagnier, Suraj Peri, Courtney Steel et al. · PLoS Pathogens · 2014 · 240 citations · Full text
Life Sciences, Immunology, Infectious Diseases +17
A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor Cells
Vladimir Beljanski, Christian Knaak, Charles D. Smith · Journal of Pharmacology and Experimental Therapeutics · 2010 · 111 citations · Full text
Life Sciences, Oncology, Pharmacology +17
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts
Vladimir Beljanski, Clayton S. Lewis, Charles D. Smith · Cancer Biology & Therapy · 2011 · 103 citations · Full text
Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists
Cindy Chiang, Vladimir Beljanski, Kevin Yin et al. · Journal of Virology · 2015 · 87 citations · Full text
Life Sciences, Immunology, Molecular Biology +17
1–5 of 24